stockrow
Friday 6 November 2026
Export MGRX’s income statement to Excel — free account
Mangoceuticals, Inc.
MGRX Healthcare Health Information Services
Mangoceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $456,000.00, down 26.0% from fiscal 2024.
- Revenue
- −59.1%
- EPS
- +84.2%
- Free cash flow
- +79.3%
Quarter to June 2026, against a year earlier
0.20
0.01
+5.26%
Follow MGRX
Alert me
Mangoceuticals, Inc. (MGRX) P/E ratio
Mangoceuticals, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 11 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MGRX Mangoceuticals, Inc. | n/m |
| ACON Aclarion, Inc. compare | n/m |
| WORX SCWorx Corp. compare | n/m |
| BFRG Bullfrog AI Holdings Inc. compare | n/m |
| ZCMD Zhongchao Inc. compare | n/m |
| HLTHQ Cue Health Inc. compare | n/m |
| VSEE VSee Health, Inc. compare | n/m |
| MSPR MSP Recovery, Inc. compare | n/m |
| HCTI Healthcare Triangle, Inc. compare | 0.0× |
| Health Information Services industry median | 42.0× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)